The present invention concerns a non-invasive device for the in-vivo determination of a concentration of an analyte in blood and, in preferred embodiments, a non-invasive sensor for determining blood glucose level in humans.
Glycaemia, the amount of glucose circulating in blood plasma, is the most important clinical parameter in management, diagnostics, and prevention of diabetes, hypoglycaemia, and other metabolic disorders. It is generally recognized that a proper diabetes therapy should aim at maintaining the glucose level in the blood at a value close to normal for as much of the time as possible. Since alimentation, stress, exercise, and other events have a strong influence on glucose blood level, frequent measurements of glycaemia are essential in diabetes management.
Glycaemia is only an example of a clinical parameter tied to a blood concentration. In diabetes therapy alone, other sugars, as well as the glucose fraction tied to the blood proteins are highly significant. Other analytes that are routinely measured in blood include oxygen, CO2, electrolytes, proteins, nitrogenous substances, nutrients, fats, cholesterol, and others.
Existing blood glucose meter require the extraction of a small drop of blood by pricking a fingertip with a lancet. Since a diabetes patient may have to determine its sugar level several times per day, this is clearly highly undesirable and spurred the development of non-invasive, techniques for measuring the blood concentration of glucose and other metabolites. Despite that, non-invasive in vivo measurement of clinically significant analytes in blood remains a challenge.
Many optical measurement techniques have been investigated in the attempt of developing portable meters for glucose or other analytes in blood. These include absorption spectroscopy (particularly in the infrared spectrum), elastic scattering and various types of Raman (inelastic) scattering. Despite many efforts, it is still difficult to obtain, by these means, a measurement sufficiently precise for clinical use.
It is known to measure quantitatively the concentration of various analytes in a sample by Raman scattering in laboratory samples. These techniques require, as a rule, a calibration with standard solutions of known concentration.
Instruments capable of detecting a glucose peak in a Raman spectrum from in vivo measurements are known. A reliable method of processing these spectra to obtain a measure of the glycaemia of clinical value is still lacking, among others due to the absence of a conventional calibration, especially because the condition of illumination and the optical properties of the investigated tissue can vary largely from one subject to another and from one position to another.
Photoplethysmography (PPG) is an optical technique used to detect a cardiac rhythm by observing the changes in light absorption in an irrorated tissue, for example in skin. Such techniques are used in personal exercise monitors, among others.
Several known types of photon detectors are used in Raman spectroscopy and PPG, including p-n junction photodiodes, p-i-n photodiodes (also known as PIN diodes), single photon avalanche diodes (SPAD), photomultipliers and microchannel plates.
Solid-state image sensors are used widely in cell-phones, cameras and scientific imaging devices. In these devices, the conversion of light into an electric signal is performed by an array of pinned photodetectors (PPD, not to be confused with PIN diodes), each PPD has a buried potential well region into which the photoelectron generated by impinging light can be integrated for a desired time, and a transfer gate that can be opened to transfer the integrated charge into a sense node. CMOS image sensor typically include some form of amplification in each pixel, often a source-follower transistor.
The present invention proposes an optical device for determination of the concentration of an analyte in blood that overcomes the limitation of the prior art in that it provides a reliable measurement noninvasively, and preferably continuous.
According to the invention, these aims are achieved by means of the appended claims.
The present disclosure describes in detail the preferred case in which the glycaemia is determined by Raman spectroscopy, but the invention can in fact be extended to the determination of the concentration of other analytes in blood, either by Raman spectroscopy, by fluorescence, absorption spectroscopy, or by any other suitable optical analytical technique.
The invention will be better understood with the aid of the description of an embodiment given by way of example and illustrated by the figures, in which:
In the represented example, the excitation source 60 is used, with a suitable optical device 61, to direct a beam of light 62 into the tissue 10. Preferably, the source 60 will have a narrow spectrum of emission and may be a solid-state laser, for example a VCSEL laser. The emission of the source 60 may be centred in the near UV, visible, near-infrared or mid-infrared regions of the electromagnetic spectrum.
The device of the invention is arranged to collect the optical radiation scattered back from the sample 10. Preferably, a light collection device 71 is used to increase the intensity of the received light on the detectors. Since the light emerging from the sample 10 is not collimated, a non-imaging collector such as a mirror may be used advantageously to send more light on the detectors 41 and 42.
In other variants, the light collection device 71 may be an imaging objective, and the detector 41 an image-sensing array. Such a realization would be capable not only of detecting and measuring the concentration of an analyte, but also of showing its distribution on an image.
According to the present embodiment, at least part of the scattered light received from the sample 10 is filtered by an optical band-pass or monochromator filter 72 that lets pass essentially only the wavelengths in a region of interest, which is chosen to select the characteristic Raman radiation expected from the searched analyte.
A non-represented mode of realization of the invention may include, in lieu of the monochromator filter 72 a dispersive device, like a grating or a spectrometer, and would be arranged to reconstruct the profile of the Raman spectrum 102, rather than its intensity in a region of interest. This variant can detect and measure several analytes at the same time, discriminating them by their specific peaks and signatures in the Raman spectrum. It may also allow to estimate and subtract the continuous background component, thus improving the precision of the measure.
In another variant of the invention, the light source 60 may be a tuneable narrowband source, such as a tuneable laser, or combine several individually selectable fixed-wavelength narrowband sources. Modifying the wavelength of the source amounts to shifting the spectrum 102 of
In another variant the monochromator 72 could be tuneable, thus allowing to select the characteristics emission peaks of several analytes, while keeping the wavelength of the emission source 60 constant. MEMS tuneable Fabry-Perot filters and other optical devices may be employed to this purpose.
The Raman scattering discussed above is a spontaneous process and the resulting radiation is weak. Detection of the characteristic glucose peak requires selective optical filters to attenuate the elastically-scattered radiation, and sensitive photodetectors. The precision of the technique can be improved by adopting the high-performance detector devices that will be described further on, and by enhancing the amplitude of the signature peaks over the background. Stimulated Raman scattering (SRS) and coherent Raman scattering (CARS/CSRS) are physical processes that use several laser beams to generate a resonantly-enhanced Raman signal. Other amplification mechanisms are known and could be incorporated in the present invention.
In an embodiment, the invention also comprises a photoplethysmography device generating a time-variable PPG signal indicative of the amount of blood present at any instant in the sensed region of the body. This technique is also based on the detection of the light scattered from the sensed region of the body 10 and consists in finding an approximately periodic component in the intensity that corresponds to the volume of blood present in the sensed region at any given instant. This component is in phase with the cardiac rhythm and is used in personal exercise monitors, among others, for measuring the heart's activity.
Returning to
In this example of realization of the invention, the PPG signal derives from a specific photodetector 42, separate from the Raman detector 41. Since the light sensed by the PPG detector 42 is not filtered by the monochromator 72, the PPG detector 42 works on the elastically-scattered light, whose intensity is much higher than the Raman radiation. This is advantageous because it yields a higher signal, but in variants of the invention a single photosensor sensor 41 produces a time-variable Raman signal.
In this embodiment the PPG photodetector is sensitive to light emitted from the source 60 and elastically scattered from the sample 10, The invention may include as well as variants with a distinct light source for the PPG sensor.
As shown in
In the example shown, the glucose concentration is measured by the stimulated Raman scattering. Two sources emit light of different frequencies: pump source 60a emits photons at angular frequency ωp and Stokes source 60b emits photons a of angular frequency ωS. When the difference in frequency between both photons (ωp−ωS) corresponds to that of a specific vibro-rotational transition in the molecule of glucose, the intensity of photons at frequency ωp decreases, while the intensity of photons at frequency ωS increases accordingly. The signal is resonantly enhanced and is considerably higher than that of the spontaneous Raman scattering. Preferably at least one, possibly both, of sources 60a and 60b are pulsed at a repetition rate high enough to appreciate phenomena related to the cardiac rhythm (plot 66), for example 150 Hz.
If the pump beam 62a and the Stokes beam 62b are absorbed by a glucose solution 17—as in the top part of
If the glucose solution is replaced by a volume of live irrorated tissue 10, the Raman signal 212 varies according to the instantaneous value of irroration of the tissue and to the glycaemia. Referring to
In another non-illustrated variant, the monochromator 72 is omitted and the dual detectors 41, 42 are replaced by a single wavelength-resolving detection system, generating both the Raman signal and the PPG signal. One could also imagine a compound detector comprising an array of photosensitive pixels, some responding to light in a broad band of wavelengths for the generation of the PPG signal, other responding only to light in the region of interest 105 for the searched analyte. This could be obtained by a mosaic of absorption filters, or by a grating or dispersive device, as already mentioned.
Preferably, the signal generated at the photodetectors is pre-processed by a suitable circuit before being digitized by the ADC 51. This front-end, which is not explicitly represented in the drawing, may be included in the photodetectors or separate, and could implement functions such as analogue amplification, integration, filtering, and baseline subtraction, as the circumstances require. The logic circuit 52 may be arranged to control the parameters of the front-end, for example to implement an automatic gain control or an automatic baseline subtraction.
Importantly, the logic circuit 52 is programmed to extract the amplitude 205 of the PPG signal, by a digital band-pass filter tuned on the expected cardiac frequency or any other suitable processing. This value is determined by the intensity of the excitation source and by the amount of blood present in the sensed region of the body. According to the invention, the amplitude of the PPG signal is used to extract a quantitative determination of analyte concentration from the Raman data, obviating the lack of a calibration with a standardized sample. The logic circuit MCU could determine the concentration as G∝IR/IP, where IR denotes the intensity of the Raman signal and IP that of the PPG signal.
The intensity of the Raman signal IR depends from the concentration of glucose in the sample, while the amplitude of the PPG signal is related to the fractional volume of pulsatile blood. Since both signals derive from the incident beam 62, the ratio IR/IP between the Raman signal and the PPG signal is largely independent from the variations illumination and optical propagation.
In an embodiment, if the intensity of the Raman signal is sufficient, the logic circuit 52 is programmed to analyse the time variation of the IR signal and extract a component that is correlated with the time variation of the PPG signal, or has the same frequency as the PPG signal. In this manner, the logic circuit retains only the contribution of the glucose that is contained in the pulsatile blood fraction in the sample 10 and estimates the glycaemia as G∝I′R/IP where l′R denotes a component of the Raman intensity that is correlated in time with the PPG signal, or has the same frequency.
Several devices can be used for the photodetectors 41 and 42. In a preferred realization, the device of the invention adopts pinned photodiodes (PPD), the main elements whereof are represented schematically in
Importantly, and differently form photodiodes and other photodetectors, PPD do not generate a photocurrent proportional to the incident light intensity because, in normal conditions, the photoelectrons collect in the potential well of the n region 152. photoelectrons are stored in the collecting region 152 until the barrier under the transfer gate is lowered by applying a sufficient potential to the gate electrode 154. PPD are inherently integrating devices. Another advantage of the PPD lies in their very low dark currents and shot noise, and excellent performances at low illumination levels.
At the end of the integration phase, the transfer phase shown in
In the readout final phase, visible in
Preferably, the source follower 160 performs a correlated double sampling of the potential VRST of the sense node at the reset and the potential VTRAN after the transfer. The difference VTRAN−VRST may be obtained numerically or, better, by a dedicated analogue circuit. Correlated double sampling not only remove the constant VRST value, but also reduces flicker noise.
In a possible sequence of operations—which is not however the only possible—the input of the double correlating sampling circuit of
Advantageously, the double correlated sampling stage 222 can perform the subtraction of the VRST value in a fast and precise way, with a negligible power consumption, which is of paramount importance in portable and wearable applications. The device of the invention may include several such stages to subtract the reset voltage of the pixels, VRST, as illustrated above, or to subtract a background illumination value, or other values as required by data processing. It lends itself to several modifications that may be useful on various situations, for example the values of the capacitors could be chosen to perform a weighted subtraction, and the gain of the output buffer could be different from unity.
Another improvement of the device of
A macropixel may correspond to a spatially compact cluster of pixels, to row/column of an array, or to any arrangement of pixels in the array, no matter how they are arranged on the surface, electrically connected as shown.
The macropixel disposition of
An interesting variant to the operative cycle of
The detector of
The macropixels are connected to an averaging stage 44 that collects the charges from each macropixels and averages them. The first sample of each pixel is stored in capacitors C by opening switches S2 and S3 and closing switches S1. Then switches S1 are opened, switches S2 are closed, and the second sample is stored in capacitors C′. The averaging of these samples is performed by closing the switches S3, whereby all the capacitors C, respectively C′ are connected in parallel and become, in effect two larger capacitors storing the whole charge of the respective samples. This process allows averaging and multiple sampling at negligible power consumption.
The charge stored in capacitors C is transferred to the sample-and-hold stage 45 by closing momentarily the switch S4 and digitized by the ADC 51. Then, the sample-and-hold is reset by SZ, and the switch S % is closed to sample and digitize the charge stored in capacitors C′.
It is noted that the circuit of the invention reads all the pixels in the macropixels (of the whole array) simultaneously, with consistent timing, and delivers an average illumination value, in contrast with conventional image sensors where the individual pixels are read separately in rolling fashion.
The circuit of
Number | Date | Country | Kind |
---|---|---|---|
01546/18 | Dec 2018 | CH | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/IB2019/057576 | 9/9/2019 | WO | 00 |